Skip to main content
Top
Published in: BMC Nephrology 1/2014

Open Access 01-12-2014 | Case report

The gap between calculated and actual calcium substitution during citrate anticoagulation in an immobilised patient on renal replacement therapy reflects the extent of bone loss – a case report

Authors: Matthias Klingele, Sarah Seiler, Aaron Poppleton, Philip Lepper, Danilo Fliser, Roland Seidel

Published in: BMC Nephrology | Issue 1/2014

Login to get access

Abstract

Background

Demineralisation and bone density loss during immobilisation are known phenomena. However information concerning the extent of calcium loss during immobilisation remains inconsistent within literature. This may explain why treatment of bone loss and prevention of further demineralisation is often initiated only when spontaneous bone fracture occurred.
Continuous renal replacement therapy is commonly utilised in critically ill patients with acute kidney injury requiring RRT. Regional anticoagulation with citrate for CRRT is well-established within the intensive care setting. Due to calcium free dialysate, calcium is eliminated directly as well as indirectly via citrate binding necessitating calcium substitution. In anuric patients declining calcium requirements over time reflect bone calcium liberation secondary to immobilisation. The difference between the expected and actual need for calcium infusion corresponds to calcium release from bone which is particularly impressive in patients exposed to long-term immobilisation and CRRT. We report a dialysis period in excess of 250 days with continuous renal replacement therapy and anticoagulation with citrate.

Case presentation

We present a 30-year old male with prolonged multisystem organ failure after bilateral lung transplantation, in whom during a period of 254 days the cumulative difference between expected and actual need for calcium infusion was 14.25 mol, representing an estimated calcium loss of about 571 g. Comparison of computed tomographic imaging of the lower thoracic vertebrae over this period depicts a radiographically discernible decrease in bone density from 238 to 52 Hounsfield Units. The first spontaneous fracture occurred after 6 months of immobilisation. Despite subsequent treatment with bisphosphonates and androgen therapy resulting in an increase in bone density to 90 HU a further fracture occurred.

Conclusion

In immobilised patients receiving CRRT and anticoagulation with citrate, decreasing need for calcium substitution reflects the degree of bone demineralisation corresponding with radiographic assessment of declining bone mineral density. Such a declining need for calcium substitution could be useful in clinical practice highlighting relevant bone loss which results in spontaneous fractures in immobilised critically ill patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Stewart AF, Adler M, Byers CM, Segre GV, Broadus AE: Calcium homeostasis in immobilization: an example of resorptive hypercalciuria. N Engl J Med. 1982, 306 (19): 1136-1140. 10.1056/NEJM198205133061903.CrossRefPubMed Stewart AF, Adler M, Byers CM, Segre GV, Broadus AE: Calcium homeostasis in immobilization: an example of resorptive hypercalciuria. N Engl J Med. 1982, 306 (19): 1136-1140. 10.1056/NEJM198205133061903.CrossRefPubMed
2.
go back to reference Wang PL, Meyer MM, Orloff SL, Anderson S: Bone resorption and "relative" immobilization hypercalcemia with prolonged continuous renal replacement therapy and citrate anticoagulation. Am J Kidney Dis. 2004, 44 (6): 1110-1114. 10.1053/j.ajkd.2004.09.001.CrossRefPubMed Wang PL, Meyer MM, Orloff SL, Anderson S: Bone resorption and "relative" immobilization hypercalcemia with prolonged continuous renal replacement therapy and citrate anticoagulation. Am J Kidney Dis. 2004, 44 (6): 1110-1114. 10.1053/j.ajkd.2004.09.001.CrossRefPubMed
3.
go back to reference Vico L, Collet P, Guignandon A, Lafage-Proust MH, Thomas T, Rehaillia M, Alexandre C: Effects of long-term microgravity exposure on cancellous and cortical weight-bearing bones of cosmonauts. Lancet. 2000, 355 (9215): 1607-1611. 10.1016/S0140-6736(00)02217-0.CrossRefPubMed Vico L, Collet P, Guignandon A, Lafage-Proust MH, Thomas T, Rehaillia M, Alexandre C: Effects of long-term microgravity exposure on cancellous and cortical weight-bearing bones of cosmonauts. Lancet. 2000, 355 (9215): 1607-1611. 10.1016/S0140-6736(00)02217-0.CrossRefPubMed
4.
go back to reference Hulley SB, Vogel JM, Donaldson CL, Bayers JH, Friedman RJ, Rosen SN: The effect of supplemental oral phosphate on the bone mineral changes during prolonged bed rest. J Clin Invest. 1971, 50 (12): 2506-2518. 10.1172/JCI106751.CrossRefPubMedPubMedCentral Hulley SB, Vogel JM, Donaldson CL, Bayers JH, Friedman RJ, Rosen SN: The effect of supplemental oral phosphate on the bone mineral changes during prolonged bed rest. J Clin Invest. 1971, 50 (12): 2506-2518. 10.1172/JCI106751.CrossRefPubMedPubMedCentral
5.
go back to reference Parfitt AM: Bone effects of space flight: analysis by quantum concept of bone remodelling. Acta Astronaut. 1981, 8 (9–10): 1083-1090.CrossRefPubMed Parfitt AM: Bone effects of space flight: analysis by quantum concept of bone remodelling. Acta Astronaut. 1981, 8 (9–10): 1083-1090.CrossRefPubMed
6.
go back to reference Zerwekh JE, Ruml LA, Gottschalk F, Pak CY: The effects of twelve weeks of bed rest on bone histology, biochemical markers of bone turnover, and calcium homeostasis in eleven normal subjects. J Bone Miner Res. 1998, 13 (10): 1594-1601.CrossRefPubMed Zerwekh JE, Ruml LA, Gottschalk F, Pak CY: The effects of twelve weeks of bed rest on bone histology, biochemical markers of bone turnover, and calcium homeostasis in eleven normal subjects. J Bone Miner Res. 1998, 13 (10): 1594-1601.CrossRefPubMed
7.
go back to reference Bauman WA, Spungen AM, Wang J, Pierson RN, Schwartz E: Continuous loss of bone during chronic immobilization: a monozygotic twin study. Osteoporos Int. 1999, 10 (2): 123-127. 10.1007/s001980050206.CrossRefPubMed Bauman WA, Spungen AM, Wang J, Pierson RN, Schwartz E: Continuous loss of bone during chronic immobilization: a monozygotic twin study. Osteoporos Int. 1999, 10 (2): 123-127. 10.1007/s001980050206.CrossRefPubMed
8.
go back to reference Sievanen H: Immobilization and bone structure in humans. Arch Biochem Biophys. 2010, 503 (1): 146-152. 10.1016/j.abb.2010.07.008.CrossRefPubMed Sievanen H: Immobilization and bone structure in humans. Arch Biochem Biophys. 2010, 503 (1): 146-152. 10.1016/j.abb.2010.07.008.CrossRefPubMed
9.
go back to reference Rittweger J, Simunic B, Bilancio G, De Santo NG, Cirillo M, Biolo G, Pisot R, Eiken O, Mekjavic IB, Narici M: Bone loss in the lower leg during 35 days of bed rest is predominantly from the cortical compartment. Bone. 2009, 44 (4): 612-618. 10.1016/j.bone.2009.01.001.CrossRefPubMed Rittweger J, Simunic B, Bilancio G, De Santo NG, Cirillo M, Biolo G, Pisot R, Eiken O, Mekjavic IB, Narici M: Bone loss in the lower leg during 35 days of bed rest is predominantly from the cortical compartment. Bone. 2009, 44 (4): 612-618. 10.1016/j.bone.2009.01.001.CrossRefPubMed
10.
go back to reference Need AG, Morris HA, Horowitz M, Nordin BE: Immobilization hypercalcaemia with severe bone mineral loss and hypogonadism. Postgrad Med J. 1984, 60 (704): 415-419. 10.1136/pgmj.60.704.415.CrossRefPubMedPubMedCentral Need AG, Morris HA, Horowitz M, Nordin BE: Immobilization hypercalcaemia with severe bone mineral loss and hypogonadism. Postgrad Med J. 1984, 60 (704): 415-419. 10.1136/pgmj.60.704.415.CrossRefPubMedPubMedCentral
11.
go back to reference Bergmann P, Heilporn A, Schoutens A, Paternot J, Tricot A: Longitudinal study of calcium and bone metabolism in paraplegic patients. Paraplegia. 1977, 15 (2): 147-159. 10.1038/sc.1977.20.CrossRefPubMed Bergmann P, Heilporn A, Schoutens A, Paternot J, Tricot A: Longitudinal study of calcium and bone metabolism in paraplegic patients. Paraplegia. 1977, 15 (2): 147-159. 10.1038/sc.1977.20.CrossRefPubMed
12.
go back to reference Naftchi NE, Viau AT, Sell GH, Lowman EW: Mineral metabolism in spinal cord injury. Arch Phys Med Rehabil. 1980, 61 (3): 139-142.PubMed Naftchi NE, Viau AT, Sell GH, Lowman EW: Mineral metabolism in spinal cord injury. Arch Phys Med Rehabil. 1980, 61 (3): 139-142.PubMed
13.
go back to reference Weissman C, Askanazi J, Hyman AI, Weber C: Hypercalcemia and hypercalciuria in a critically ill patient. Crit Care Med. 1983, 11 (7): 576-578. 10.1097/00003246-198307000-00020.CrossRefPubMed Weissman C, Askanazi J, Hyman AI, Weber C: Hypercalcemia and hypercalciuria in a critically ill patient. Crit Care Med. 1983, 11 (7): 576-578. 10.1097/00003246-198307000-00020.CrossRefPubMed
14.
go back to reference Peacock M: Calcium metabolism in health and disease. Clin J Am Soc Nephrol. 2010, 5 (Suppl 1): S23-S30.CrossRefPubMed Peacock M: Calcium metabolism in health and disease. Clin J Am Soc Nephrol. 2010, 5 (Suppl 1): S23-S30.CrossRefPubMed
15.
go back to reference Sbaihi M, Rousseau K, Baloche S, Meunier F, Fouchereau-Peron M, Dufour S: Cortisol mobilizes mineral stores from vertebral skeleton in the European eel: an ancestral origin for glucocorticoid-induced osteoporosis?. J Endocrinol. 2009, 201 (2): 241-252. 10.1677/JOE-08-0492.CrossRefPubMed Sbaihi M, Rousseau K, Baloche S, Meunier F, Fouchereau-Peron M, Dufour S: Cortisol mobilizes mineral stores from vertebral skeleton in the European eel: an ancestral origin for glucocorticoid-induced osteoporosis?. J Endocrinol. 2009, 201 (2): 241-252. 10.1677/JOE-08-0492.CrossRefPubMed
16.
go back to reference Gruenewald DA, Matsumoto AM: Testosterone supplementation therapy for older men: potential benefits and risks. J Am Geriatr Soc. 2003, 51 (1): 101-115. 10.1034/j.1601-5215.2002.51018.x. discussion 115CrossRefPubMed Gruenewald DA, Matsumoto AM: Testosterone supplementation therapy for older men: potential benefits and risks. J Am Geriatr Soc. 2003, 51 (1): 101-115. 10.1034/j.1601-5215.2002.51018.x. discussion 115CrossRefPubMed
17.
go back to reference Lopez-Herce J, Santiago MJ, Solana MJ, Urbano J, del Castillo J, Carrillo A, Bellon JM: Clinical course of children requiring prolonged continuous renal replacement therapy. Pediatr Nephrol. 2010, 25 (3): 523-528. 10.1007/s00467-009-1378-4.CrossRefPubMed Lopez-Herce J, Santiago MJ, Solana MJ, Urbano J, del Castillo J, Carrillo A, Bellon JM: Clinical course of children requiring prolonged continuous renal replacement therapy. Pediatr Nephrol. 2010, 25 (3): 523-528. 10.1007/s00467-009-1378-4.CrossRefPubMed
18.
go back to reference Rajgopal R, Bear M, Butcher MK, Shaughnessy SG: The effects of heparin and low molecular weight heparins on bone. Thromb Res. 2008, 122 (3): 293-298. 10.1016/j.thromres.2006.10.025.CrossRefPubMed Rajgopal R, Bear M, Butcher MK, Shaughnessy SG: The effects of heparin and low molecular weight heparins on bone. Thromb Res. 2008, 122 (3): 293-298. 10.1016/j.thromres.2006.10.025.CrossRefPubMed
Metadata
Title
The gap between calculated and actual calcium substitution during citrate anticoagulation in an immobilised patient on renal replacement therapy reflects the extent of bone loss – a case report
Authors
Matthias Klingele
Sarah Seiler
Aaron Poppleton
Philip Lepper
Danilo Fliser
Roland Seidel
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2014
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-15-163

Other articles of this Issue 1/2014

BMC Nephrology 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.